Screening compound: C30H37N5O2 (L627-1097)

Screening compound: C<sub>30</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub> (L627-1097)
Screening compound: C<sub>30</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub> (L627-1097) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C30H37N5O2 (L627-1097)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L627-1097

Molecular Formula

C30H37N5O2 (C30 H37 N5 O2)

Compound Name

N-[1-(3,4-dimethylphenyl)ethyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide

IUPAC name

N-[1-(34-dimethylphenyl)ethyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl]methyl}benzamide

SMILES

CC(c1cc(C)c(C)cc1)NC(c1ccc(CN(CC2)Cc3c2n(C)nc3C(N2CCCC2)=O)cc1)=O

InChI

InChI=1S/C30H37N5O2/c1-20-7-10-25(17-21(20)2)22(3)31-29(36)24-11-8-23(9-12-24)18-34-16-13-27-26(19-34)28(32-33(27)4)30(37)35-14-5-6-15-35/h7-12,17,22H,5-6,13-16,18-19H2,1-4H3,(H,31,36)/t22-/m0/s1

InChI Key

UVDIPHRXDKMEGP-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD27466133

C30H37N5O2 (L627-1097) in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

CNS Targets (44014 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Nucleic Acid Ligands (8311 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Nervous system
  • Cardiovascular
Targets:
  • Proteases
  • Ion Channels

References: we are preparing a list of scientific research reports with C30H37N5O2 (L627-1097) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C30H37N5O2 (L627-1097)?
Check Price and Availability of C30H37N5O2 (L627-1097), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C30H37N5O2 (L627-1097) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C30H37N5O2 (L627-1097)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C30H37N5O2 (L627-1097)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C30H37N5O2 (L627-1097) available by request